Skip to content
Support Us
Support Us
  • Contact us
St. Anna CCRI
  • Research
  • Institute
  • News
  • Careers
St. Anna CCRI
Support Us
Support Us
  • Groups
  • Publications
  • Core Facilities
  • National & International Grants
  • Job Openings
  • Institute
  • Working at St. Anna CCRI
  • News
  • Contact us
Back
  • Research Groups
  • Core Facilities
  • Grants
  • Publications
  • Affiliated Clinicians
  • Reports
Back
  • Boztug Group
  • Cresswell Group
  • Dworzak Group
  • Grebien Group
  • Halbritter Group
  • Hutter Group
  • Kameneva Group
  • Lion Group
  • Salzer Group | Physician Scientist
  • Seruggia Group
  • Taschner-Mandl Group
  • Tomazou Group
  • Christian Doppler Laboratory
  • Clinical Trials Unit | Attarbaschi
  • Former Groups
  • All Research Groups
Back
  • Kovar Group
  • Strehl Group
Back
  • Research Management Office
  • National & International Grants
Back
  • Mission
  • History
  • Management
  • Administration
  • Science Communication, PR & Marketing
  • Funding
Back
  • Job Openings
  • Working at St. Anna CCRI
  • Recruiting and Onboarding
Back
  • Mission
  • History
  • Management
  • Administration
  • Science Communication, PR & Marketing
  • Funding

News

Alternative method to animal testing for developing therapies

Congrats to Davide Seruggia for receiving the ISTT Young Investigator Award!

OnTheTrack

St. Anna CCRI research project ONTHETRRAC honored as “success story”

Decoding the epigenome and its regulation in neuroblastoma

Somatic Sex – the development of malignant diseases reinterpreted

“Rare diseases are also an emergency!”

Executive board of Europe’s neuroblastoma network SIOPEN

EU Commissioner visits St. Anna

Kaan Boztug awarded the “Işil Berat Barlan Award”

Bone marrow metastases for the first time analyzed cell by cell

Four FWF Stand Alone Projects recently approved at St. Anna CCRI

Study identifies better tolerable chemotherapy without loss of efficacy

A new language for congenital immune disorders

“1000 Ideas” to boost childhood cancer research

a new role for histone modifications in genomic imprinting

Gene defect shortens survival and needs targeted treatment

Beitrags-Navigation

« Previous 1 … 10 11 12 Next »

St. Anna Kinderkrebsforschung GmbH
Zimmermannplatz 10
1090 Vienna 
Austria

T: +43 1 40470 0
F: +43 1 40470 7150

  • About
  • Labdia
  • Kinderkrebsforschung
  • Privacy Policy
  • Whistleblowing
  • Imprint

FOLLOW US:

  • Facebook
  • YouTube
  • Twitter
  • LinkedIn
  • Instagram

© 2026 St. Anna CCRI

To change your privacy setting, e.g. granting or withdrawing consent, click here: Settings